Send the following on WhatsApp
Continue to ChatFDA Approves KYPROLIS® (carfilzomib) In Combination With Dexamethasone For Patients With Relapsed Or Refractory Multiple Myeloma https://cyclodextrinnews.com/2018/10/16/fda-approves-kyprolis-carfilzomib-in-combination-with-dexamethasone-for-patients-with-relapsed-or-refractory-multiple-myeloma/